dna
glycosylas
emerg
relev
pharmacolog
target
inflamm
cancer
neurodegen
diseas
consequ
search
inhibitor
enzym
becom
activ
research
field
continu
previou
work
show
irrevers
inhibitor
zinc
finger
znf
contain
fpgnei
dna
glycosylas
design
synthes
minilibrari
txn
evalu
abil
inhibit
fpgnei
enzym
among
forti
compound
four
txn
better
inhibitor
fpg
unexpectedli
interestingli
two
dithiol
deriv
select
effici
inhibit
zincless
finger
znlf
contain
enzym
human
mimiviru
dna
glycosylas
respect
combin
chemistri
biochemistri
mass
spectrometri
blind
flexibl
dock
xray
structur
analysi
local
new
txn
bind
site
fpgnei
enzym
endeavor
allow
us
deciph
atom
level
mode
action
best
txn
inhibitor
znfcontain
enzym
discov
origin
inhibit
mechan
znlfcontain
fpgnei
dna
glycosylas
disulfid
cyclic
trimer
form
dithiopurin
work
pave
way
design
synthesi
new
structur
class
inhibitor
select
pharmacolog
target
cancer
neurodegen
diseas
dna
constitut
element
continu
subject
deleteri
effect
physic
chemic
agent
endogen
environment
sourc
induc
dna
structuralchem
chang
interfer
dna
transact
replic
transcript
recombin
reactiv
oxygen
speci
h
etc
result
cell
respiratori
metabol
inflammatori
process
water
radiolysi
ioniz
radiat
fenton
reaction
photo
activ
process
respons
format
numer
oxidationdegrad
product
nucleobas
miscod
abas
site
oxid
base
mislead
block
replic
transcript
machineri
result
mutat
cell
death
structur
dna
chang
initi
inflamm
carcinogenesi
agerel
neurodegen
process
counteract
advers
effect
organ
bacteriophag
virus
evolv
numer
dna
repair
strategi
basic
principl
conserv
evolut
among
strategi
major
way
repair
oxid
base
base
excis
repair
ber
pathway
ber
initi
dna
glycosylas
recogn
remov
base
lesion
result
abas
ap
site
excis
combin
action
ap
endonucleas
ap
lyas
drp
lyas
reaction
lead
one
nucleotid
gap
final
dna
polymeras
dna
ligas
cooper
fill
gap
restor
dna
integr
addit
involv
mainten
genet
materi
dna
repair
dna
glycosylas
also
key
enzym
involv
myriad
physiolog
process
particip
matur
immunoglobulin
antigen
somat
hypermutagenesi
sm
classswitch
recombin
csr
via
uracildna
glycosylas
mainten
telomer
via
dna
glycosylas
enzymat
mechan
activ
dna
demethyl
via
dna
glycosylas
tdg
human
dna
glycosylas
emerg
new
pharmacolog
target
smallmolecul
modul
given
role
wide
rang
physiolog
andor
possibl
patholog
process
huntington
diseas
hd
andor
initi
repair
oxid
pyrimidin
cag
triplet
propos
trigger
iter
oxidationexcis
cycl
contribut
somat
instabl
huntingtin
gene
cag
repeat
expans
strikingli
somat
cag
repeat
instabl
hd
highest
striatum
tissu
preferenti
affect
diseas
unbalanc
ber
enzym
activ
seem
respons
tissueselect
diseas
thu
select
inhibitor
direct
striatum
might
prevent
cag
repeat
expans
anoth
exampl
small
interf
rna
sirna
screen
approach
highlight
synthet
lethal
interact
thymidyl
synthas
ts
pathway
sever
human
dna
glycosylas
osteosarcoma
cell
recent
studi
new
mechan
propos
sustain
prolifer
ra
transform
cell
increas
ber
capabl
mechan
rastransform
cell
use
stimul
overcom
antiprolif
effect
excess
oxid
dna
damag
observ
may
provid
new
therapeut
window
cancer
therapi
might
exploit
select
drug
specif
target
recent
studi
demonstr
relev
research
design
innov
anticanc
strategi
report
search
inhibitor
previou
work
initi
studi
dna
glycosylas
structur
fpgnei
superfamili
enzym
recogn
excis
oxid
base
dna
catalyz
cleavag
nglycosyd
bond
damag
base
associ
sugar
enzym
bifunct
dna
glycosylas
associ
ap
lyas
activ
involv
success
cleavag
phosphodiest
bond
side
result
ap
site
mechan
fpgnei
dna
glycosylas
compos
two
globular
domain
ntermin
domain
rich
betastructur
ctermin
domain
rich
alphastructur
enzym
display
helixtwo
turnshelix
motif
involv
dna
bind
contain
origin
zinc
finger
znf
motif
defin
new
class
znf
compris
structur
gener
four
cystein
residu
coordin
zn
ion
type
cx
c
h
x
cx
c
small
number
enzym
lack
znf
instead
similar
motif
free
zinc
call
zincless
finger
znlf
site
direct
mutagenesi
crystal
structur
enzym
bound
damag
dna
show
znf
znlf
play
exactli
role
dna
bind
although
structur
relat
display
slight
overlap
substrat
specif
enzym
fpg
subfamili
remov
oxid
purin
wherea
nei
subfamili
specif
oxid
pyrimidin
bacteri
fpg
enzym
excis
major
oxid
product
purin
thu
consid
function
homolog
structur
unrel
eukaryot
glycosylas
effort
exploit
extrahel
base
lesion
recognit
mechan
use
enzym
remov
oxid
base
identifi
among
purin
pyrimidin
deriv
inhibitor
bacteri
fpg
nei
enzym
human
surprisingli
enzym
kinet
experi
escherichia
coli
fpg
protein
propos
uncompetit
inhibit
mode
word
effect
inhibitor
target
probabl
activ
site
enzym
accord
uncompetit
inhibit
mode
bind
enzymesubstr
complex
interact
favor
prior
bind
enzym
dna
substrat
fact
demonstr
free
bound
enzym
target
slight
prefer
bound
enzym
compat
mix
inhibit
rather
uncompetit
noncompetit
inhibit
studi
solut
coupl
crystal
structur
analysi
reveal
two
znf
cystein
residu
possibl
target
effect
result
loss
zinc
observ
solut
crystal
structur
coval
attach
cystein
disulfid
bond
thu
irrevers
inhibit
enzym
enzym
target
site
howev
exclud
irrevers
charact
inhibit
high
concentr
compromis
correct
interpret
enzymat
kinet
data
although
znf
oxid
mechan
mediat
remain
unclear
explain
lack
znf
resist
strong
disulfid
reduc
tri
phosphin
hydrochlorid
tcep
protect
znfcontain
enzym
inhibitori
effect
work
synthet
small
librari
deriv
evalu
effect
bacteri
llfpg
lactococcu
lacti
eukaryot
model
human
mimiviru
dna
glycosylas
identifi
inhibitor
effici
znfcontain
fpgnei
dna
glycosylas
surprisingli
inhibit
znlfcontain
neilik
protein
mainli
base
chemic
biochem
mass
spectrometri
comput
structur
approach
deciph
atom
level
mechan
action
best
inhibitor
znfcontain
enzym
llfpg
propos
possibl
inhibitori
mechan
enzym
fpgnei
superfamili
contain
znf
compound
identifi
dna
base
analog
screen
uncompetit
inhibitor
e
coli
formamidopyrimidinedna
glycosylas
ecfpg
confirm
inhibitori
effect
znfcontain
enzym
fpgnei
dna
glycosylas
structur
superfamili
includ
llfpg
ecnei
although
precis
mode
action
remain
clarifi
establish
solut
xray
analysi
chemic
select
target
two
expos
cystein
residu
znf
enzym
consequ
coval
attach
cystein
disulfid
bond
zinc
ion
releas
order
find
select
effici
inhibitor
clarifi
inactiv
mode
thiolthion
group
prepar
minilibrari
txn
see
supplementari
inform
synthesi
figur
structur
txn
screen
abil
inactiv
glycosylaseap
lyas
activ
llfpg
fpg
model
xray
structur
investig
compound
thiolfre
other
monothiol
dithiol
compound
figur
expect
compound
without
thiolthion
group
unabl
effici
inhibit
excis
dna
llfpg
figur
howev
presenc
thiolthion
group
test
compound
seem
insuffici
inhibit
enzym
inde
thiocompound
low
unmeasur
effect
fpg
glycosylaseap
lyas
activ
figur
appar
halfmaxim
inhibitori
concentr
app
best
compound
obtain
doserespons
curv
figur
tabl
figur
averag
standard
deviat
obtain
least
three
independ
experi
monoand
dithiol
compound
highlight
red
blue
respect
b
doserespons
curv
best
inhibitor
data
point
repres
mean
valu
obtain
least
three
independ
measur
halfmaxim
inhibitori
inhibit
valu
app
effici
txn
indic
tabl
extract
data
use
origin
softwar
two
test
dithiocompound
inhibit
fpg
rang
magnitud
effici
monothiocompound
find
indic
noncumul
effect
thiol
function
fpg
inhibit
tabl
best
inhibitor
monothiocompound
seven
time
effect
app
tabl
group
might
respons
better
interact
compound
fpg
replac
methyl
group
drastic
decreas
inhibitori
effect
despit
presenc
thiolthion
group
figur
posit
thiogroup
thionethiol
appear
essenti
inhibit
occupi
posit
purin
aromat
ring
txn
effect
inhibitor
alreadi
shown
tcep
strong
reduc
disulfid
bond
counteract
inhibitori
effect
txn
figur
purin
moieti
effici
txn
compound
seem
crucial
thiocompound
inhibit
fpg
figur
figur
consid
fpg
repair
oxid
purin
last
observ
suggest
txn
might
interact
enzym
activ
site
kinet
experi
llfpg
presenc
partial
support
last
hypothesi
figur
although
llfpg
inhibit
e
coli
homolog
ecfpg
raw
kinet
data
experi
appear
complic
difficult
interpret
outcom
suggest
sever
inhibitori
mechan
concomitantli
contribut
final
inhibitori
process
previou
work
identifi
irrevers
inhibitori
mechan
result
oxid
znf
protein
case
inhibitori
constant
ki
determin
mechan
also
support
inhibit
suppress
tcep
figur
like
superimpos
inhibitori
mechan
factor
make
difficult
analyz
kinet
data
clarifi
separ
analyz
kinet
data
obtain
low
high
concentr
figur
expect
observ
linear
depend
reciproc
veloc
function
reciproc
substrat
concentr
without
inhibitor
kinet
constant
valu
excis
llfpg
k
nm
v
max
fmolmin
k
cat
min
valu
compar
well
determin
previous
excis
fapyg
ecfpg
low
concentr
inhibitori
process
appear
partial
competit
appar
k
k
ic
valu
consist
interact
activ
site
enzym
inhibitori
mechan
previous
describ
ecfpg
enzym
high
concentr
inhibit
display
clear
uncompetit
mechan
decreas
v
k
ratio
remain
rel
invari
appar
k
k
iu
alreadi
observ
ecfpg
mode
inhibit
agreement
possibl
bind
outsid
activ
site
free
bound
enzym
later
discuss
difficulti
interpret
enzymat
kinet
data
presenc
txn
also
explain
differ
redox
equilibrium
state
compound
dimethyl
sulfoxid
dmso
easili
control
add
addit
complex
loss
inhibit
presenc
tcep
also
suggest
reduc
form
txn
weakli
effect
inhibit
enzym
see
complement
studi
examin
effect
txn
bind
fpg
short
dna
duplex
contain
tetrahydrofuran
thf
noncleav
ap
site
analog
enzym
specif
recogn
thf
form
stabl
abort
complex
dna
qualit
quantit
bind
experi
perform
electrophoret
mobil
shift
assay
emsa
dna
bind
condit
optim
dmso
requir
txn
dissolut
neg
affect
enzym
stabil
activ
bovin
serum
albumin
bsa
requir
avoid
enzym
dilut
neg
effect
obtain
reproduc
result
figur
repres
titrat
experi
without
tcep
thf
c
dna
duplex
llfpg
shown
figur
fpg
form
two
stabl
complex
short
dna
probe
easili
observ
emsa
highaffin
complex
correspond
lesion
recognit
complex
lrc
nanomolar
affin
complex
observ
higher
fpg
concentr
result
titrat
second
fpg
molecul
find
illustr
crystal
structur
fpg
bound
dna
figur
stabil
preform
complex
examin
emsa
presenc
txn
experi
choic
preform
complex
ad
txn
reaction
mixtur
base
observ
preincub
fpg
min
c
txn
inhibitor
concentr
rang
vari
micromolar
millimolar
complet
abolish
enzym
abil
bind
dna
data
unambigu
indic
txn
effect
inhibitor
interact
enzym
even
absenc
dna
result
consist
noncompetit
inhibit
fpg
mechan
also
partial
suggest
enzymat
kinet
studi
high
concentr
inhibitor
previou
work
figur
inde
mechan
suggest
inactiv
enzym
indiffer
interact
enzym
alon
enzymesubstr
complex
outsid
enzym
activ
site
enzym
inactiv
mediat
znf
oxid
directli
affect
dna
bind
properti
enzym
also
agreement
last
observ
doserespons
curv
preform
presenc
increas
thiocompound
concentr
show
effect
inhibit
fpg
activ
induc
dissoci
fpgdna
lesion
recognit
complex
figur
inhibitor
concentr
induc
loss
halfmaxim
bind
app
b
determin
curv
report
tabl
app
b
compar
well
app
observ
enzym
activ
strong
reduc
tcep
abolish
neg
effect
txn
fpgdna
complex
stabil
format
find
indic
inhibit
thiocompound
essenti
reli
oxid
fpg
znf
exampl
see
experi
figur
surprisinglyand
high
concentr
txn
mm
effect
txn
stabil
complex
preform
complex
treatment
presenc
tcep
highli
variabl
molar
ratio
tcep
strongli
destabil
remain
stabl
figur
condit
moder
effect
troubl
unexpect
observ
led
us
evalu
effect
txn
small
librari
compound
prevent
side
effect
due
possibl
partial
reduct
tcep
perform
emsa
presenc
molar
excess
tcep
respect
txn
complex
format
figur
tabl
expect
presenc
tcep
thiolthion
function
txn
absolut
criterion
among
best
destabil
found
compound
lack
thiol
group
includ
contrari
presenc
alkyl
group
trifluoromethyl
methyl
group
posit
two
purin
deriv
figur
favor
destabil
data
suggest
txn
compound
interact
fpg
llfpg
unknown
enzym
bind
site
find
result
incompet
second
fpg
molecul
form
complex
thf
c
dna
duplex
obvious
bind
compound
exosit
limit
effect
stabil
fpg
molecul
bound
lesion
lrc
figur
crystal
structur
llfpg
bound
c
dna
duplex
differ
use
studi
damag
natur
present
duplex
lesion
place
thf
reveal
second
fpg
molecul
bind
overhang
base
posit
end
damag
strand
figur
structur
first
fpg
molecul
figur
alreadi
posit
base
lesion
physic
interact
second
one
figur
combin
biochem
structur
observ
propos
txn
select
bind
fpg
outsid
activ
site
exosit
action
impair
abil
bind
overhang
base
dna
duplex
end
accord
hypothesi
txn
mimic
overhang
base
dna
duplex
displac
phenomenon
destabil
high
affin
txn
occupi
exosit
fpg
appear
unabl
form
complex
molecular
dock
experi
crystal
structur
present
confirm
hypothesi
previou
work
show
inhibit
znfcontain
fpgnei
dna
glycosylas
ecfpg
ecnei
llfpg
high
concentr
inhibit
essenti
result
znf
oxid
associ
zinc
releas
zincless
znlf
contain
enzym
appear
resist
complement
present
studi
evalu
txn
effect
catalyt
dna
bind
activ
two
znlf
enzym
regard
capac
oxid
cystein
thiolat
txn
two
protein
good
complementari
model
display
eight
free
cystein
residu
wherea
lack
cystein
note
llfpg
contain
four
cystein
residu
involv
zn
ion
coordin
znf
motif
anticip
test
monothiol
txn
compound
significantli
affect
oppos
effect
llfpg
figur
interestingli
unexpectedli
two
dithiol
txn
evalu
studi
display
appar
inhibitori
effect
catalyt
dna
bind
activ
one
two
thiolthion
group
substitut
posit
two
purin
ring
second
substitut
posit
six
eight
purin
analog
respect
although
monothiol
txn
ineffect
enzym
inhibit
might
attribut
potenti
chemic
reactiv
free
cystein
residu
complet
devoid
cystein
best
inhibitor
respect
tabl
base
knowledg
among
best
inhibitor
znlfcontain
fpgnei
enzym
discov
date
previou
work
use
highthroughput
screen
small
molecul
librari
lloyd
group
identifi
purin
analog
determin
radioassay
similar
assay
although
difficult
conclud
mechan
inhibit
inhibit
inhibit
attribut
attack
cystein
simplest
hypothesi
explain
result
interact
either
activ
site
andor
anoth
site
impair
abil
enzym
bind
andor
metabol
dna
substrat
mode
inhibit
might
also
exist
llfpg
hypothesi
would
explain
difficult
extract
enzymat
kinet
precis
mode
inhibit
sever
mechan
inhibit
contribut
final
inhibit
observ
figur
astonish
find
studi
lie
observ
strong
reduc
tcep
lesser
extent
dithiothreitol
dtt
suppress
inhibit
dna
bind
catalyt
activ
mediat
figur
consid
tcep
power
reduc
agent
break
disulfid
bond
compar
dtt
cysteinefre
enzym
inhibit
simplest
hypothesi
explain
last
observ
propos
reduc
direct
action
enzym
protein
oxid
protect
well
accord
proposit
suggest
disulfid
form
possibl
oxid
form
potenti
respons
inhibit
due
presenc
two
thiolthion
group
exclud
possibl
mani
oligomer
form
compound
stock
solut
simplest
way
evalu
molecular
homogen
txn
stock
dmso
solut
use
studi
content
analysi
mass
spectrometri
ms
given
direct
analysi
sampl
matrixassist
laser
desorptionionizationtim
flight
malditof
electrospray
ioniz
esi
ms
imposs
due
presenc
dmso
use
highresolut
esim
coupl
liquid
chromatographi
separ
lchrm
lchrm
analysi
perform
stock
solut
monothio
dithio
figur
stock
solut
unambigu
contain
two
major
compound
one
expect
mass
reduc
form
figur
red
red
second
one
mass
consist
correspond
disulfid
dimer
form
figur
ox
ox
lchrm
spectrum
display
complex
lcprofil
find
indic
greater
heterogen
compound
dmso
molecular
speci
elut
peak
one
two
may
correspond
reduc
form
lost
one
sulfur
atom
um
compound
elut
peak
three
correspond
reduc
form
figur
red
two
compound
later
elut
separ
later
display
molecular
mass
expect
two
cyclic
trimer
disulfid
isom
figur
figur
b
propos
thioldisulfid
exchang
mechan
inhibit
zinc
fingercontain
fpgnei
enzym
disulfid
form
indic
cystein
thiolatecontain
zinc
finger
fpgnei
enzym
belong
disulfid
form
thiocompound
ident
differ
divers
oxid
speci
present
dmso
stock
solut
appear
restrict
two
possibl
cyclic
isom
trimer
disulfid
speci
disulfid
linear
speci
dimer
trimer
oligom
cyclic
oligomer
disulfid
oxid
speci
involv
less
three
monom
possibl
multipl
redox
state
txn
stock
solut
rais
question
form
molecul
respons
fpgnei
dna
glycosylas
inhibit
observ
previou
experi
strongli
suggest
involv
disulfid
form
txn
inhibit
fpgnei
dna
glycosylas
tcep
complet
abolish
inhibit
enzym
test
work
figur
confirm
hypothesi
establish
experiment
procedur
prepar
homogen
disulfid
form
monothiocompound
use
sodium
period
naio
appropri
oxid
use
produc
disulfid
speci
rather
oxid
speci
figur
avoid
dmsomedi
oxid
dri
powder
homogen
reduc
oxid
speci
dissolv
mm
sodium
phosphat
effect
homogen
redox
form
compound
evalu
separ
catalyt
activ
dna
bind
properti
llfpg
figur
disulfid
form
ox
ox
inhibit
fpg
catalyt
activ
respect
right
panel
figur
b
contrast
red
red
inhibit
enzym
left
panel
figur
valu
activ
approxim
time
greater
app
determin
redox
mixtur
dmso
tabl
drew
similar
conclus
regard
effect
disulfid
form
dna
bind
properti
llfpg
b
figur
b
obtain
homogen
speci
alway
time
greater
data
suggest
catalyt
activ
dna
bind
experiment
condit
differ
compar
incub
temperatur
dna
probe
protein
concentr
etc
nevertheless
two
measur
activ
vari
direct
observ
tabl
ox
twice
effect
ox
inhibit
llfpg
data
show
select
txn
expect
given
result
experi
use
redox
mixtur
dmso
neither
ox
ox
inhibit
figur
select
monothio
compound
protein
znf
inhibit
llfpg
monothiolcompound
dithiocompound
sure
result
thioldisulfid
exchang
mechan
thiolat
znf
cystein
disulfid
form
txn
monothioor
dithiocompound
figur
even
cystein
thiolat
znf
potenti
involv
thioldisulfid
exchang
mechan
previous
show
expos
llfpg
znf
suscept
form
disulfid
bond
howev
complet
exclud
similar
mechan
particip
inhibit
notabl
fail
observ
coval
adduct
mass
spectrometri
malditof
follow
long
incub
compound
low
reactiv
free
cystein
residu
might
link
fact
buri
structur
protein
therefor
access
solvent
thu
obvious
thioldisulfid
exchang
mechan
complet
exclud
cystein
despit
mani
attempt
fail
prepar
solubl
homogen
form
although
doubt
oxid
trimer
cyclic
form
respons
inhibit
protein
provid
experiment
proof
process
exhaust
search
potenti
interact
site
dock
consid
intrins
flexibl
receptor
free
dna
bound
protein
ligand
conform
tautom
describ
materi
method
section
figur
present
overview
key
step
blind
flexibl
dock
procedur
use
perform
dock
experi
redox
ligand
free
dna
bound
llfpg
exampl
dock
ox
conform
describ
pictur
figur
red
red
two
bind
site
propos
site
includ
activ
site
site
ii
mainli
includ
two
dna
bind
motif
found
fpgnei
dna
glycosylas
znf
znlf
loop
contain
strictli
conserv
residu
respect
motif
figur
figur
bind
site
partial
compos
amino
acid
directli
involv
catalysi
strictli
conserv
residu
partli
lesion
cap
loop
lcl
loop
residu
differ
fpg
nei
subfamili
figur
tabl
potenti
bind
thiocompound
activ
site
consist
competit
inhibit
mode
suggest
fpg
kinet
experi
analyz
low
concentr
see
text
figur
bind
site
ii
area
partli
constitut
strictli
conserv
llfpg
residu
local
helix
motif
local
first
turn
respect
figur
strictli
conserv
arginin
znf
znlf
loop
llfpg
respect
neutral
dna
phosphat
group
locat
side
damag
nucleosid
often
mobil
interact
reduc
form
dna
present
structur
seem
hydrophob
interact
hydrogen
bond
dna
also
contribut
bind
reduc
oxid
site
ii
figur
phenomenon
appear
especi
true
nucleotid
phosphat
local
side
thf
damag
nucleosid
see
zinc
coordin
sphere
llfpg
znf
identifi
red
red
bind
site
dock
experi
bind
red
red
site
ii
ie
outsid
activ
site
free
dna
bound
enzym
might
associ
uncompetit
noncompetit
inhibit
suggest
llfpg
kinet
experi
analyz
high
concentr
figur
howev
biochem
data
effect
presenc
tcep
ie
reduc
speci
consist
hypothesi
discrep
suggest
bind
red
red
site
andor
ii
would
associ
fpgnei
enzym
inhibit
complement
biochem
data
show
disulfid
form
respons
enzym
inhibit
figur
perform
blind
dock
experi
ox
ox
disulfid
form
figur
figur
reveal
two
major
bind
site
free
dna
bound
enzym
correspond
bind
site
ii
alreadi
identifi
red
red
figur
f
interestingli
third
ox
bind
site
name
bind
site
iii
locat
site
ii
also
propos
dock
experi
free
enzym
figur
h
figur
figur
amino
acid
residu
line
bind
site
iii
list
tabl
belong
bind
site
ii
bind
site
iii
hidden
fpgnei
enzym
bound
dna
figur
f
base
data
propos
llfpg
inhibit
result
bind
disulfid
form
cyclic
trimer
form
figur
site
iii
occup
site
iii
ox
might
prevent
dna
bind
thu
catalysi
best
dock
pose
site
iii
ox
free
enzym
clash
dna
present
crystal
structur
bound
thymin
glycol
tg
contain
dna
figur
particular
superimpos
flip
tg
base
damag
lrc
complex
thu
dock
experi
provid
reason
inhibit
dithiocompound
figur
tabl
show
protein
residu
mobil
stabil
dock
ligand
site
iii
hydrogen
bond
protein
residu
ligand
shown
red
dash
line
hydrophob
interact
grey
arc
circl
catalyt
residu
highlight
orang
residu
known
interact
directli
flip
oxid
pyrimidin
tg
color
magenta
residu
blue
involv
lesion
cap
loop
essenti
stabil
flip
damag
nucleosid
insid
activ
site
pocket
residu
green
involv
intercal
loop
protein
insert
dna
minor
groov
hole
result
flip
damag
nucleosid
figur
similar
observ
made
free
llfpg
understand
txn
mode
action
solv
sever
crystal
structur
llfpg
bound
thf
c
lrc
presenc
thiocompound
end
crystal
llfpgdna
complex
soak
satur
solut
mother
liquor
previous
describ
use
method
success
resolv
structur
lrc
moder
potent
inhibitor
new
crystal
structur
higheffici
inhibitor
loweffici
inhibitor
presenc
tcep
tabl
despit
sever
attempt
fail
obtain
structur
effici
inhibitor
harbor
substitut
purin
ring
case
crystal
structur
display
one
molecul
fpg
dna
duplex
observ
second
molecul
bind
dna
duplex
extrem
observ
llfpg
bound
duplex
contain
place
thf
figur
absenc
reduc
previous
observ
crystal
structur
show
induc
oxid
znf
cystein
residu
concomit
loss
zn
ion
present
structur
llfpgdna
znf
cystein
residu
oxid
two
expos
llfpg
cystein
residu
form
intermolecular
disulfid
bridg
one
molecul
two
cystein
residu
establish
intramolecular
disulfid
bond
figur
show
fpg
oxid
product
crystal
structur
exquisit
support
thioldisulfid
exchang
mechan
propos
inhibit
znfcontain
fpgnei
dna
glycosylas
txn
clear
electron
densiti
near
sulfur
atom
accord
thioldisulfid
molecular
mechan
figur
last
observ
suggest
either
intermolecular
disulfid
bond
labil
use
crystal
condit
spontan
hydrolysi
oxid
coval
link
txn
molecul
dynam
gener
interpret
electron
densiti
similar
crystal
structur
intramolecular
disulfid
bridg
also
form
presenc
txn
observ
previous
one
molecul
noncoval
bound
enzym
insert
proteindna
interfac
vicin
znf
loop
motif
figur
b
two
dna
bind
domain
character
fpgnei
dna
glycosylas
superfamili
new
bind
site
includ
site
ii
propos
blind
dock
experi
describ
figur
similar
noncoval
bind
site
ii
also
observ
txn
figur
among
best
dock
pose
observ
similar
correspond
crystal
structur
figur
last
observ
valid
dock
procedur
use
strictli
conserv
residu
znf
loop
loop
ntermin
llfpg
domain
directli
involv
recognit
figur
guanidinium
group
side
chain
interact
uniqu
sulfur
atom
sulfur
atom
posit
without
tcep
atom
purin
moieti
epsilon
amino
group
side
chain
interact
sulfur
atom
compound
znf
llfpg
znlf
respect
key
fpgnei
residu
involv
dna
bind
essenti
neutral
electroneg
dna
phosphat
border
damag
nucleosid
allow
enzym
bend
dna
dna
bend
facilit
extrus
damag
nucleosid
outsid
dna
helix
stabil
insid
activ
site
pocket
expos
catalysi
addit
role
dna
bind
also
propos
accessori
catalyt
residu
dna
glycosylas
activ
ecfpg
bind
site
ii
present
crystal
structur
indic
reduc
form
disturb
local
structur
complex
dna
backbon
conform
side
chain
orient
unchang
absenc
tcep
observ
fixat
disulfid
form
site
ii
probabl
consum
oxid
protein
znf
transform
reduc
speci
potenti
consist
thioldisulfid
exchang
mechan
propos
figur
fpg
presenc
tcep
incub
mixtur
prevent
znf
oxid
crystal
structur
fpg
bound
thf
c
presenc
tcep
reveal
nativ
structur
znf
preserv
one
molecul
reduc
form
still
observ
site
ii
tabl
anticip
dock
experi
enzymedna
complex
noncoval
bind
site
dock
site
ii
seen
composit
area
partli
form
protein
dna
backbon
phosphat
twothre
nucleotid
side
damag
nucleotid
figur
phosphat
group
thi
interact
sulfur
group
txn
phosphat
group
nucleotid
thi
atom
atom
atom
group
substitut
atom
figur
howev
bind
red
alter
local
dna
structur
protein
thu
like
bind
reduc
speci
site
ii
littl
impact
fpgnei
protein
activ
dna
bind
presenc
tcep
disulfid
form
reduc
thu
unabl
inhibit
fpgnei
protein
figur
addit
suggest
occup
site
ii
monoor
dithiotxn
txn
without
thiolthion
group
incompat
fixat
second
fpg
molecul
end
dna
duplex
figur
thu
bind
small
molecul
site
ii
may
impair
format
complex
without
tcep
observ
emsa
experi
fpg
crystal
structur
llfpg
bound
dna
duplex
figur
figur
inde
fine
inspect
crystal
structur
lesion
recognit
complex
resolv
presenc
show
overhang
cytosin
damagecontain
strand
recogn
second
molecul
llfpg
clash
bound
site
ii
figur
structur
featur
provid
satisfactori
explan
understand
txn
without
thiolthion
group
presenc
tcep
inhibit
format
figur
figur
stage
investig
exclud
bind
disulfid
form
monothio
site
ii
contribut
global
inhibit
znfcontain
fpgnei
dna
glycosylas
observ
suggest
dock
experi
cyclic
disulfid
form
dithio
speci
might
respons
inhibit
znlfcontain
fpgnei
subclass
enzym
interact
particularli
site
iii
free
enzym
propos
relev
site
iii
identifi
dock
experi
actual
exist
complet
devoid
cystein
good
model
tri
answer
question
unfortun
despit
numer
attempt
succeed
crystal
presenc
redox
equilibrium
mixtur
overview
structur
b
g
zoom
noncoval
bind
site
ie
bind
site
ii
respect
absenc
tcep
h
superimposit
insid
llfpg
noncoval
bind
site
base
peptid
backbon
align
protein
thf
abas
site
analog
highlight
magenta
ntermin
activ
site
prolin
indic
ballandstick
model
use
repres
txn
sulfur
atom
indic
yellow
ball
intraand
intermolecular
disulfid
bond
yellow
stick
direct
interact
thiopurin
side
chain
fpg
residu
thiopurin
dna
backbon
phosphat
side
thf
indic
grey
dash
line
figur
superimposit
crystal
structur
llfpg
bound
dna
duplex
magenta
crystal
structur
llfpg
bound
thf
contain
dna
duplex
presenc
green
view
second
llfpg
molecul
bound
extrem
duplex
visibl
overview
see
figur
pdbid
clariti
dna
voluntarili
omit
overhang
cytosin
damag
strand
shown
cyan
sodium
period
tcep
purchas
sigmaaldrich
chemic
use
prepar
correspond
homodisulfid
compound
suppli
mp
biomed
chemcruz
respect
design
synthesi
procedur
txn
use
studi
describ
supplementari
inform
molecul
powder
dissolv
mm
final
concentr
buffer
contain
mm
hepesnaoh
dmso
mm
kcl
glycerol
store
month
c
wild
type
llfpg
overproduc
fpg
defect
e
coli
strain
purifi
describ
previous
human
nucleotid
sequenc
clone
express
vector
gift
dr
susann
wallac
mimiviru
open
read
frame
codon
optim
genscript
clone
protein
cterminu
overproduc
e
coli
strain
autoinduc
medium
protein
purifi
three
liquid
chromatographi
step
use
hp
sp
hp
prepack
column
ge
healthcar
chicago
illinoi
usa
protein
final
concentr
respect
buffer
contain
mm
hepesnaoh
mm
nacl
mm
tcep
glycerol
truncat
form
use
emsa
experi
orf
code
fuse
ctermin
codon
optim
genscript
clone
recombin
use
transform
strain
overproduct
perform
describ
full
length
protein
purifi
describ
concentr
buffer
contain
mm
hepesnaoh
ph
mm
nacl
mm
dtt
glycerol
purif
protein
store
c
flash
cool
liquid
nitrogen
synthet
oligodeoxyribonucleotid
odn
use
studi
purchas
eurogentec
catalyt
dna
bind
activ
emsa
lesioncontain
strand
label
terminu
p
atp
use
polynucleotid
kinas
p
label
lesioncontain
strand
ctgatcgatgaxgcctgacatgat
x
dihydrouracil
dhu
anneal
cold
complementari
strand
atcatgtcaggcytcatcgatcag
indic
c
g
result
dna
duplex
c
og
c
dhu
g
dhu
g
use
substrat
measur
catalyt
activ
fpg
respect
p
label
lesioncontain
strand
ctctttxtttctcg
x
tetrahydrofuran
thf
ap
site
analog
anneal
cold
complementari
strand
gcgagaaacaaaga
gener
thf
c
dna
duplex
thf
c
use
emsa
experi
see
cold
thf
c
dna
duplex
also
use
crystal
fpgdna
complex
previous
describ
fpg
bifunct
dna
glycosylas
associ
concert
dna
glycosylas
activ
cleavag
nglycosid
bond
base
lesion
deoxyribos
ap
lyas
activ
compris
success
cleavag
phosphodiest
bond
result
abas
ap
site
respect
thu
ap
site
result
excis
damag
base
quantit
convert
one
nucleosid
gap
enzym
dna
glycosylaseap
lyas
activ
enzym
measur
incub
nm
dna
duplex
og
c
dhu
g
fpg
respect
label
damag
strand
see
nm
fpg
min
nm
min
c
mm
trishcl
ph
mm
nacl
mm
edta
mgml
bsa
dmso
reaction
stop
addit
volum
formamid
load
buffer
formamid
mm
trishcl
ph
mm
na
edta
heat
c
min
analyz
ureapag
previous
describ
electrophoresi
gel
expos
autoradiographi
reveal
use
typhoon
imag
quantifi
imagequ
softwar
condit
substrat
convert
cleavag
product
limit
enzym
concentr
condit
initi
evalu
inhibitori
effect
use
thiocompound
ad
reaction
mixtur
final
addit
enzym
competit
condit
best
identifi
inhibitor
doserespons
curv
gener
determin
figur
tabl
dna
bind
activ
measur
use
emsa
briefli
nm
label
thf
c
see
incub
enzym
c
min
mm
hepesnaoh
ph
mm
nacl
glycerol
mgml
bsa
dmso
incub
mixtur
load
onto
nativ
polyacrylamid
gel
acrylbi
electrophores
vcm
min
c
electrophoresi
gel
dri
expos
overnight
autoradiographi
use
typhoon
imag
quantifi
imagequ
softwar
evalu
inhibitor
effect
dna
bind
activ
fpgnei
enzym
first
determin
experiment
condit
requir
bind
dna
probe
without
inhibitor
presenc
dmso
limit
enzym
concentr
condit
obtain
halfmaxim
dna
bind
nm
fpg
use
limit
enzym
concentr
evalu
inhibitor
effect
enzym
dna
bind
activ
effect
determin
addit
thiocompound
preequilibrium
mixtur
enzym
dna
probe
min
incub
addit
min
c
best
inhibitor
fpg
doserespons
curv
establish
least
three
independ
experi
determin
b
tabl
four
structur
use
receptor
ligand
dock
model
free
fpg
l
lacti
llfpg
obtain
remov
dna
duplex
xray
structur
enzym
bound
thfcontain
dna
duplex
ii
xray
structur
llfpgdnathf
complex
pdbidcod
iii
xray
structur
free
pdbidcod
miss
residu
reconstruct
use
prime
modul
llc
new
york
ny
http
wwwschrodingercom
iv
xray
structur
bound
thfdna
pdbidcod
four
system
place
rectangular
box
explicit
water
molecul
buffer
ensur
neutral
system
counter
ion
ad
system
energi
minim
molecular
dynam
md
simul
ps
perform
temperatur
increas
k
step
reach
target
temperatur
k
equilibr
perform
seven
md
step
ps
posit
restraint
heavi
atom
increment
decreas
kcal
system
ns
md
product
run
perform
npt
ensembl
conform
store
everi
ps
analysi
energi
minim
md
simul
shake
algorithm
use
fs
time
step
integr
equat
motion
particl
mesh
ewald
summat
use
electrostat
calcul
cutoff
period
boundari
condit
appli
md
simul
amber
packag
amber
forc
field
use
http
ambermdorg
two
system
contain
thf
tetrahydrofuran
geometri
charg
distribut
thf
residu
comput
use
gaussian
program
http
gaussiancom
fit
resp
program
compat
cornel
et
al
forc
field
adapt
paramet
system
hierarch
ascend
cluster
hac
method
averag
linkag
distanc
calcul
use
classifi
system
conform
cluster
base
rmsd
map
configur
trajectori
compar
other
extract
one
structur
call
centroid
cluster
centroid
repres
system
flexibl
within
singl
cluster
thirti
collect
centroid
use
dock
studi
reduc
disulfid
form
sketch
within
sybyl
suit
structur
calcul
concord
energi
minim
disulfid
dimer
sever
conform
search
techniqu
random
search
ga
search
confort
default
paramet
set
sybyl
packag
use
repres
set
conform
obtain
exhaust
possibl
set
cyclic
conform
dock
use
sever
method
random
search
grid
search
simul
anneal
implement
sybyl
packag
certara
nj
usa
default
paramet
prepar
dock
surflexdock
surflex
manual
dock
similar
version
may
biopharm
llc
santa
fe
ca
usa
protomol
gener
protein
structur
centroid
automat
mode
default
paramet
sybyl
interfac
protomol
seen
imprint
interact
caviti
protein
dock
studi
perform
geomx
mode
option
set
spindens
premin
remin
multistart
divrm
ndockfin
ring
precalcul
conform
surflexdock
gener
subsequ
conform
prior
dock
twenti
pose
propos
end
llfpgdna
complex
prepar
mix
molar
excess
thf
c
dna
duplex
llfpg
crystal
room
temperatur
presenc
dmso
absenc
tcep
use
previous
describ
method
crystal
tcep
obtain
soak
crystal
llfpgdna
complex
txn
satur
mother
liquor
soak
crystal
flash
cool
liquid
nitrogen
xray
diffract
data
set
collect
k
beamlin
soleil
pari
esrf
grenobl
data
process
use
xd
packag
program
scala
structur
solv
molecular
replac
use
crystal
structur
wild
type
llfpg
protein
bound
thf
c
pdb
id
code
previous
describ
xray
data
collect
refin
statist
present
tabl
structur
cartoon
gener
dna
glycosylas
initi
base
excis
repair
ber
constitut
first
line
defens
oxid
stress
result
nucleobas
oxid
paradox
high
level
oxid
stress
viral
bacteri
infect
cancer
cell
cell
patient
suffer
inflammatori
diseas
huntington
diseas
give
reason
hope
dna
glycosylas
relev
pharmacolog
target
precis
patholog
situat
although
mani
dna
repair
enzym
consid
therapeut
target
advantag
select
target
dna
glycosylas
cancer
neurodegen
diseas
emerg
recent
redund
dna
glycosylas
substrat
specif
observ
singl
ko
mous
viabl
fertil
long
hamper
search
inhibitor
enzym
yet
situat
ideal
case
synthet
lethal
interact
patholog
context
dna
glycosylas
last
year
search
inhibitor
dna
glycosylas
becom
activ
field
start
research
discov
irrevers
inhibitor
bacteri
enzym
fpg
nei
human
enzym
three
enzym
belong
fpgnei
dna
glycosylas
structur
superfamili
zinc
finger
znf
interestingli
enzym
superfamili
resist
inhibitori
effect
clearli
demonstr
abl
irrevers
oxid
fpg
znf
although
inhibit
mechan
remain
elucid
find
provid
explan
permit
understand
resist
know
enzym
znf
present
work
describ
discoveri
biochem
character
new
structur
fpg
inhibitor
screen
small
librari
deriv
txn
initi
goal
studi
find
inhibitor
effect
deciph
mode
action
thiocompound
fpgnei
dna
glycosylas
four
txn
monoor
dithiothiopurin
better
fpg
inhibitor
especi
seven
time
effect
anticip
previou
studi
txn
test
unabl
inhibit
expect
begin
studi
howev
two
dithiopurin
evalu
also
effici
inhibit
dna
glycosylas
devoid
znf
know
free
cystein
inhibit
seem
mysteri
even
curiou
tcep
power
reduc
disulfid
bridg
annihil
inhibitor
effect
glycosylas
activ
dna
bind
similar
effect
observ
action
tcep
presenc
monothiocompound
suggest
tcep
act
directli
combin
mass
spectrometri
chemistri
biochemistri
xray
structur
analysi
demonstr
disulfid
form
equilibrium
reduc
form
dmso
mixtur
respons
inhibit
fpgnei
enzym
although
reduc
abl
bind
free
dna
bound
enzym
propos
blind
dock
confirm
xray
crystal
structur
ternari
complex
bind
either
site
ii
activ
site
site
observ
without
tcep
probabl
associ
inhibit
disulfid
known
inhibit
sever
enzym
accord
variou
mechan
unsymmetr
aromat
disulfid
obtain
monothiol
compound
inhibit
sarscov
pro
import
target
fight
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
probabl
interact
catalyt
cystein
contain
proteas
pro
li
et
al
report
synthesi
unsymmetr
aromat
disulfid
novel
inhibitor
herbicid
acetohydroxyacid
synthas
plant
microorgan
enzym
involv
biosynthesi
branchedchain
amino
acid
reynold
cowork
publish
unsymmetr
arylalkyl
disulfid
select
inhibit
methicillinresist
staphylococcu
aureu
bacillu
anthraci
use
disulfid
select
target
human
znfand
znlfcontain
fpgnei
dna
glycosylas
therapi
howev
condit
activ
plasma
antioxid
power
mediat
human
serum
albumin
hsa
presenc
cell
reduc
glutathion
gsh
remain
determin
take
account
potenti
reduct
disulfid
inhibitor
hsa
enzym
assay
present
work
perform
presenc
bsa
bovin
function
homolog
hsa
regard
gsh
mix
disulfid
glutathion
gsscompound
retain
vivo
activ
patholog
context
associ
high
level
oxid
stress
antioxid
power
gsh
hsa
greatli
reduc
thu
incap
counter
action
disulfid
aromat
disulfid
shown
activ
vivo
antitumor
agent
case
znfcontain
fpgnei
enzym
demonstr
znf
oxid
result
thioldisulfid
exchang
mechan
cystein
residu
coordin
zn
ion
disulfid
thu
disulfid
act
zn
ejector
result
case
irrevers
inhibit
mechan
alreadi
propos
inhibit
symmetr
disulfid
induc
select
oxid
zn
ii
coordin
cystein
center
activ
site
natur
symmetr
disulfid
psammaplin
isol
spong
analog
describ
antitumor
agent
strongli
inhibit
dna
methyltransferas
dnmt
histon
deacethylas
hdac
interf
respect
zn
center
thioldisulfid
exchang
mechan
result
znf
oxid
zn
releas
also
propos
inhibit
nucleocapsid
protein
zn
ejector
diba
symmetr
disulfid
blind
flexibl
dock
also
suggest
inhibit
partli
result
bind
disulfid
activ
site
site
andor
site
ii
strike
result
studi
discoveri
disulfid
form
dithiotxn
also
capabl
inhibit
znlfcontain
fpgnei
dna
glycosylas
like
show
thiocompound
exist
dmso
solut
equilibrium
red
two
cyclic
trimer
disulfid
form
bind
site
ii
emsa
experi
blind
flexibl
dock
suggest
inhibitori
effect
ox
could
effect
free
dna
bound
dock
disulfid
reveal
third
bind
site
site
iii
access
free
fpg
site
realli
exist
bind
fpg
dna
could
inhibit
disulfid
occupi
site
iii
selfassembl
properti
aromat
dithiocompound
cyclic
disulfid
disulfid
cyclophan
known
long
time
chemist
thu
symmetr
unsymmetr
disulfid
use
tool
creat
small
molecul
librari
dynam
combinatori
chemistri
dcl
recent
method
adapt
search
enzym
inhibitor
use
protein
molecular
trap
name
proteindirect
combinatori
chemistri
pdcc
combin
fragmentbas
screen
method
pdcc
altern
expens
highthroughput
screen
ht
chemic
librari
enabl
explor
larger
chemic
space
effici
manner
work
modestli
illustr
interest
strategi
find
new
enzym
inhibitor
potenti
protein
target
site
inspir
design
new
class
inhibitor
discoveri
disulfid
cyclophan
inhibit
fpg
constitut
start
point
explor
new
avenu
find
new
potent
inhibitor
origin
structur
use
pdcc
combin
fragmentbas
screen
process
implement
strategi
